Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases

J Antimicrob Chemother. 2003 Aug;52(2):152-4. doi: 10.1093/jac/dkg306. Epub 2003 Jul 1.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems / methods*
  • Epstein-Barr Virus Infections / drug therapy*
  • Epstein-Barr Virus Infections / genetics*
  • Herpesvirus 4, Human / drug effects
  • Herpesvirus 4, Human / genetics*
  • Humans
  • Oligonucleotide Array Sequence Analysis / methods
  • Viral Matrix Proteins / genetics
  • Viral Matrix Proteins / isolation & purification*
  • Viral Matrix Proteins / metabolism

Substances

  • EBV-associated membrane antigen, Epstein-Barr virus
  • Viral Matrix Proteins